Type 2 Diabetes
The prevalence of type 2 diabetes has increased dramatically in recent years, and is projected to nearly double in coming decades. The importance of blood glucose control in preventing microvascular complications, such as retinopathy and nephropathy, is well established. However, according to the most current patient data, approximately one-third of patients diagnosed with type 2 diabetes are not receiving pharmacotherapy to achieve recommended glycemic control.
Modern Management of Pregnancy Complicated by Diabetes
Lois Jovanovic, MD, Sansum Diabetes Research Institute, Santa Barbara, CA
Therapy for Type 2 Diabetes: Fundamental Concepts for Primary Care
Irl B. Hirsch, MD, University of Washington School of Medicine, Seattle, WA
Insulin Therapy: Barriers and Solutions
Martin S. Lipsky, MD, Univ. of Illinois College of Medicine, Rockford, IL
Richard Bergenstal, MD, International Diabetes Center, Park Nicollett Institute, Minneapolis, MN
A Practical Approach to Insulin Therapy in Type 2 Diabetes Mellitus
Daniel Einhorn, MD, Diabetes and Endocrine Associates, La Jolla, CA
Type 2 Diabetes: Pathogenesis and Rationale for a New Therapeutic Model
Mark Stolar, MD, Northwestern Univ. Feinberg School of Medicine, Chicago, IL
Practical Strategies for the Early Management of Type 2 Diabetes
Stanley H. Hsia, MD, Charles Drew Univ. of Medicine and Science, Los Angeles, CA
Martin S. Lipsky, MD, Univ. of Illinois College of Medicine at Rockford, IL
Melissa Sujak, RD, LDN, CDE, Northwestern Memorial Hosp., Chicago, IL
Early Management of Type 2 Diabetes Mellitus
Stanley H. Hsia, MD, Charles Drew Univ. of Medicine and Science, Los Angeles, CA
